12 | 13 | | A BILL TO BE ENTITLED 1 |
---|
13 | 14 | | AN ACT APPROPRIATING FUNDS TO THE DEPARTMENT OF HEALTH AND HUMAN 2 |
---|
14 | 15 | | SERVICES, DIVISION OF PUBLIC HEALTH, TO PROVIDE GRANTS TO NONPROFIT 3 |
---|
15 | 16 | | COMMUNITY HEALTH CENTERS FOR THE PURCHASE AND DISTRIBUTION OF 4 |
---|
16 | 17 | | LONG-ACTING REVERSIBLE CONTRACEPTIVES. 5 |
---|
17 | 18 | | The General Assembly of North Carolina enacts: 6 |
---|
18 | 19 | | SECTION 1. There is appropriated from the General Fund to the Department of 7 |
---|
19 | 20 | | Health and Human Services, Division of Public Health, the sum of two million five hundred 8 |
---|
20 | 21 | | thousand dollars ($2,500,000) in recurring funds for each year of the 2025-2027 fiscal biennium 9 |
---|
21 | 22 | | to be used to award grants on a competitive basis to nonprofit community health centers. 10 |
---|
22 | 23 | | Nonprofit community health centers selected to receive these grant funds shall use all such funds 11 |
---|
23 | 24 | | to purchase and make available long-acting reversible contraceptives for underserved, uninsured, 12 |
---|
24 | 25 | | or medically indigent patients. As used in this section, the term "long-acting reversible 13 |
---|
25 | 26 | | contraceptives" means a contraceptive drug or device that meets all of the following criteria: 14 |
---|
26 | 27 | | (1) Is a method of birth control that provides effective contraception for an 15 |
---|
27 | 28 | | extended period of time without depending upon user action. 16 |
---|
28 | 29 | | (2) Is designed as a temporary method of birth control that the user can elect to 17 |
---|
29 | 30 | | discontinue. 18 |
---|
30 | 31 | | (3) Has been approved by the United States Food and Drug Administration for 19 |
---|
31 | 32 | | use as a contraceptive. 20 |
---|
32 | 33 | | (4) Is obtained under a prescription written by a health care provider authorized 21 |
---|
33 | 34 | | to prescribe medications under the laws of this State. 22 |
---|
34 | 35 | | SECTION 2. This act becomes effective July 1, 2025. 23 |
---|